arrow
E

Eun Soo Kim

kyungpook national university hospital
H指数:36
被引数:4,625

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Distinct predictive factors for acute severe ulcerative colitis in East Asian and Western populations

东亚和西方人群中急性重度溃疡性结肠炎的不同预测因素

2026-06-050
OAAI
Practices and perceptions of imaging assessment in inflammatory bowel disease: a nationwide survey of physicians in Korea by KASID Guidelines Taskforce Team

炎症性肠病影像评估的实践与认知:韩国消化内镜学会指南任务组开展的一项全国性医师调查

2026-04-010
OA
One-year effectiveness and safety of ustekinumab treatment in patients with ulcerative colitis: an Asan-Crohn's and Colitis Association in Daegu-Gyeongbuk (CCAiD) multicenter real-world cohort study

奥马珠单抗治疗溃疡性结肠炎患者的一年有效性与安全性:一项大邱庆北克罗恩病与结肠炎协会(CCAiD)多中心真实世界队列研究

2026-01-010
PRE
Enterotype-based stratification identifies clinically distinct microbial subtypes in inflammatory bowel disease

基于肠型的分层识别出炎症性肠病中临床不同的微生物亚型

2026-01-010
PRE
Acute severe ulcerative colitis patients from Asia have lower colectomy risk than patients from Australasia

亚洲的急性重症溃疡性结肠炎患者较大洋洲的患者具有更低的结肠切除术风险。

2025-10-300
PRE
Practices and perceptions of 5-aminosalicylic acid use in Crohn's disease: a nationwide survey of physicians in Korea by KASID Guidelines Taskforce Team

5-氨基水杨酸在克罗恩病中的应用实践与认知:韩国KASID指南工作组开展的一项全国性医师调查

2025-10-010
OAAI
Comparative efficacy of subcutaneous infliximab switching in remission and non-remission patients with inflammatory bowel disease after intravenous maintenance: 1-year outcome from a multicentre cohort study

静脉维持治疗后炎症性肠病患者的皮下英夫利昔单抗转换治疗比较疗效:一项多中心队列研究的一年结果

2025-04-230
OA
G Protein-Coupled Estrogen Receptor-Mediated Anti-Inflammatory and Mucosal Healing Activity of a Trimethylpyridinol Analogue in Inflammatory Bowel Disease
2024-06-191
PRE